ClinConnect ClinConnect Logo
Search / Trial NCT05569096

Tregs CD25 CXCL9 in Vitiligo

Launched by ASSIUT UNIVERSITY · Oct 3, 2022

Trial Information

Current as of July 04, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Tregs CD25 CXCL9 in Vitiligo," is studying how certain immune cells and proteins in the blood might help us understand the activity of vitiligo, a skin condition that causes loss of pigmentation. The researchers want to see if measuring these immune cells and proteins can give us better insight into how the disease is progressing in patients with non-segmental vitiligo.

To participate in this study, individuals must be diagnosed with non-segmental vitiligo and be between the ages of 18 and 75. However, people who have recently received systemic treatments or have other autoimmune diseases like rheumatoid arthritis or lupus will not be eligible to join. If you qualify, you can expect to provide blood samples for testing. This research is still in the planning stages, so the study is not yet recruiting participants. Your involvement could contribute to important discoveries about vitiligo and help improve understanding and treatment options for this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:The patients will be enrolled in the study if they have :-
  • Non segmental vitiligo.
  • Exclusion Criteria:
  • The following patients were excluded from this study:
  • Patients receiving systemic treatment in the last two months.
  • Patients with any autoimmune disease, such as rheumatoid arthritis. inflammatory bowel disease, psoriasis, or systemic lupus erythematosus; patients with type 1 diabetes mellitus.
  • Patients with any thyroid and/or neoplastic diseases.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials